Department of Colorectal Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China.
Colorectal Dis. 2011 Apr;13(4):414-9. doi: 10.1111/j.1463-1318.2009.02179.x.
In this study we explored the prognostic impact of synchronous bilateral prophylactic oophorectomy in female patients with primary colorectal cancer undergoing radical surgery.
From 1991 to 2000, 267 female patients with stage II or stage III colorectal cancer, who had undergone curative resection, were retrospectively reviewed. In 224 patients, the ovaries were preserved. The other 43 patients underwent synchronous bilateral prophylactic oophorectomy. Univariate and multivariate analyses (Kaplan-Meier and Cox regression, respectively) were used to evaluate the effect of prophylactic oophorectomy and other clinical factors on the prognosis of patients.
Both univariate and multivariate analyses showed that tumor stage and adjuvant chemotherapy were the only two significant clinical factors that affected the 5-year overall survival of patients (P < 0.01). There was no significant difference in the 5-year overall survival between patients who had, or had not, undergone prophylactic oophorectomy (75%vs 73%, P > 0.05). In the subgroup analysis by adjuvant chemotherapy, the 5-year overall survival in patients receiving adjuvant chemotherapy was similar between nonoophorectomy and oophorectomy groups. However, in patients without adjuvant chemotherapy, the oophorectomy group was shown to have a significantly better 5-year overall survival than the nonoophorectomy group (76%vs 51%, P = 0.047).
Prophylactic oophorectomy may improve the overall survival of female patients with locally advanced colorectal cancer without adjuvant chemotherapy, but its survival benefit vanished in patients receiving adjuvant chemotherapy. The role of prophylactic oophorectomy may be substituted by adjuvant chemotherapy, which makes prophylactic oophorectomy unnecessary during surgery for locally advanced colorectal cancer.
本研究旨在探讨女性原发性结直肠癌根治术后同期双侧预防性卵巢切除术对患者预后的影响。
回顾性分析 1991 年至 2000 年间 267 例接受根治性手术的Ⅱ期或Ⅲ期结直肠癌女性患者的临床资料。其中 224 例患者保留卵巢,43 例患者同期行双侧预防性卵巢切除术。采用单因素和多因素分析(分别为 Kaplan-Meier 法和 Cox 回归分析)评估预防性卵巢切除术和其他临床因素对患者预后的影响。
单因素和多因素分析均显示,肿瘤分期和辅助化疗是影响患者 5 年总生存率的唯一两个显著临床因素(P<0.01)。预防性卵巢切除与未切除患者的 5 年总生存率无显著差异(75%比 73%,P>0.05)。在辅助化疗亚组分析中,接受辅助化疗的患者中,卵巢切除术组与未切除组的 5 年总生存率相似。然而,在未接受辅助化疗的患者中,卵巢切除术组的 5 年总生存率明显优于未切除组(76%比 51%,P=0.047)。
对于未接受辅助化疗的局部晚期结直肠癌女性患者,预防性卵巢切除术可能提高总体生存率,但在接受辅助化疗的患者中,其生存获益消失。辅助化疗可能替代预防性卵巢切除术的作用,使局部晚期结直肠癌手术时无需行预防性卵巢切除术。